Logo image of AEGN

Aegion Corp (AEGN) Stock Fundamental Analysis

NASDAQ:AEGN - Nasdaq -

29.99  -0.01 (-0.03%)

After market: 29.95 -0.04 (-0.13%)

Fundamental Rating

1

Overall AEGN gets a fundamental rating of 1 out of 10. We evaluated AEGN against 0 industry peers in the Unkown industry. AEGN has a bad profitability rating. Also its financial health evaluation is rather negative. AEGN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AEGN had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -3.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.54%
PM (TTM) -3.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

AEGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

AEGN has an Altman-Z score of 2.91. This is not the best score and indicates that AEGN is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.46 indicates that AEGN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 2.91
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

AEGN has a Current Ratio of 2.14. This indicates that AEGN is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.92 indicates that AEGN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.92

More info and screens

1

3. Growth

3.1 Past

AEGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.31%.
AEGN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.88% yearly.
The Revenue for AEGN has decreased by -25.88% in the past year. This is quite bad
AEGN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.54% yearly.
EPS 1Y (TTM)-21.31%
EPS 3YN/A
EPS 5Y-3.88%
EPS Q2Q%33.33%
Revenue 1Y (TTM)-25.88%
Revenue growth 3YN/A
Revenue growth 5Y-9.54%
Sales Q2Q%-36.95%

3.2 Future

Based on estimates for the next years, AEGN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.67% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y7.62%
EPS Next 2Y8.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AEGN Yearly Revenue VS EstimatesAEGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
AEGN Yearly EPS VS EstimatesAEGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.24, which means the current valuation is very expensive for AEGN.
Compared to an average S&P500 Price/Earnings ratio of 29.62, AEGN is valued at the same level.
AEGN is valuated rather expensively with a Price/Forward Earnings ratio of 24.19.
The average S&P500 Price/Forward Earnings ratio is at 22.70. AEGN is around the same levels.
Industry RankSector Rank
PE 31.24
Fwd PE 24.19
AEGN Price Earnings VS Forward Price EarningsAEGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 47.77
AEGN Per share dataAEGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AEGN does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.1
PEG (5Y)N/A
EPS Next 2Y8.67%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AEGN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Aegion Corp

NASDAQ:AEGN (5/14/2021, 8:21:15 PM)

After market: 29.95 -0.04 (-0.13%)

29.99

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)03-09 2022-03-09/dmh
Inst Owners0%
Inst Owner Change0%
Ins Owners1.83%
Ins Owner Change0%
Market Cap922.49M
Analysts60
Price Target29.92 (-0.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.24
Fwd PE 24.19
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB N/A
EV/EBITDA 47.77
EPS(TTM)0.96
EY3.2%
EPS(NY)1.24
Fwd EY4.13%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS29.5
BVpS13.32
TBVpSN/A
PEG (NY)4.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.54%
PM (TTM) -3.24%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.92
Altman-Z 2.91
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.31%
EPS 3YN/A
EPS 5Y-3.88%
EPS Q2Q%33.33%
EPS Next Y7.62%
EPS Next 2Y8.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.88%
Revenue growth 3YN/A
Revenue growth 5Y-9.54%
Sales Q2Q%-36.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A